# Sentante

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sentante

- Industry: Medical Devices & Equipment
- Headquarters: Kaunas, Lithuania
- Website: www.sentante.com
- Total disclosed funding: $6.5M
- Latest round: Seed (Dec 21, 2023)
- Investors on record: 2

## About

Founded in 2017 and based in Kaunas, Lithuania, Sentante provides a fully robotic teleoperated system for endovascular interventions. The company was co-founded by Edvardas Satkauskas (CEO), Dr. Tomas Baltrunas (CMO), and Dr. Evaldas Kalvaitis (COO). In December 2023, Sentante raised EUR 6 million in seed funding led by new investor Practica Capital, with participation from another new investor EIC Fund. The company will use the funding to carry out crucial clinical trials for its robotic technology and get ready for its launch into particular international markets.

The company offers Sentante which is a robotic system for endovascular procedures. Sentante is a teleoperated robotic system that is intelligent and sensitive. It enables remote surgery from a separate room, shielding doctors from dangerous X-rays and creating new opportunities for telesurgery.

## Funding rounds

- Seed, Dec 21, 2023, $6.5M — Practica Capital, European Innovation Council

## Investors

- Practica Capital (https://capitalatlas.ai/funds/practica-capital) — Seed
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Seed